Details of Epigenetic Molecule(EM)
| General Information of EM (ID: EM12233) | |||||||
|---|---|---|---|---|---|---|---|
| Official Symbol |
MST1
|
||||||
| Official Full Name |
Macrophage Stimulating 1
|
||||||
| Synonym |
Macrophage Stimulating 1;D3F15S2;DNF15S2;NF15S2;HGFL;MSP;Macrophage Stimulatory Protein;Hepatocyte Growth Factor-Like;EC 3.4.21;Macrophage Stimulating 1 (Hepatocyte Growth Factor-Like);Macrophage-Stimulating Protein;Hepatocyte Growth Factor-Like Protein
|
||||||
| Molecule Type |
Protein coding
|
||||||
| Position On Chromosome |
chr3(Start:49683947 - End:49689523)
|
||||||
| Strand |
-
|
||||||
| Uniprot Entry | |||||||
| ENSG ID | |||||||
| Disease Relevance (Click to Show/Hide) | |||||||
| 2C30: Melanoma of skin | Cutaneous Melanoma [Melanoma of skin] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| 8A20: Alzheimer disease | Alzheimer's disease [Alzheimer disease] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| CB03: Idiopathic interstitial pneumonitis | Idiopathic pulmonary fibrosis (IPF) [Idiopathic interstitial pneumonitis] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| SE30: Developmental delay disorder | CHARGE and Kabuki syndromes [Developmental delay disorder] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| XH4XG8: Chronic myeloid leukaemia | Chronic Phase-Chronic Myeloid Leukemia [Chronic myeloid leukaemia] | ||||||
| Detailed Information |
Disease Link
click to show the detail information of this Disease
|
||||||
| Metabolite(s) with this epigenetic modification | |||||||
|---|---|---|---|---|---|---|---|
| Metabolite Name: Resveratrol | |||||||
| Detailed Information |
Meta Info
click to show the detail information of this Metabolite
|
[1], [2] | |||||
| Description |
Resveratrol could change tumor suppressor gene MST1 from hypermethylated to hypomethylated status in MDA-MB-231 breast cancer cells treated with resveratrol (100 M) at 48 h.
|
||||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
